Company news
Exicure, Inc. news in 2019
Exicure, Inc.'s news releases, calls and decks from 2019, newest first.
Exicure Announces the Closing of its Offering of Common Stock
December 22, 2019
Exicure Announces Pricing of $27.5 Million Public Offering of Common Stock
December 18, 2019
Exicure Announces Proposed Public Offering of Common Stock
December 17, 2019
Exicure Announces First Neurological Development Program in Friedreich’s Ataxia and Expands Scientific Advisory Board
December 15, 2019
Exicure Reports Activity of AST-008 in Patients with Merkel Cell Carcinoma and Will Enroll Patients in Phase 2 Study
December 10, 2019
Exicure and Allergan Enter Into Collaboration, Option and License Agreement to Discover and Develop SNA-based Treatments for Hair Loss Disorders
November 13, 2019
Exicure Reports Third Quarter 2019 Financial Results and Recent Developments
November 6, 2019
Exicure Presents Positive Biomarker Results from Clinical Trial of XCUR17
October 15, 2019
Decks in 2019
- Corporate Update (June 2019)
Corporate update · 13 slides · Jun 27, 2019